Cargando…
Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells
BACKGROUND: The Ras pathway genes KRAS, BRAF, or ERBBs have somatic mutations in ~ 60% of human colorectal carcinomas. At present, it is unknown whether the remaining cases lack mutations activating the Ras pathway or whether they have acquired mutations in genes hitherto unknown to belong to the pa...
Autores principales: | Kundu, Snehangshu, Ali, Muhammad Akhtar, Handin, Niklas, Padhan, Narendra, Larsson, Jimmy, Karoutsou, Maria, Ban, Kenneth, Wiśniewski, Jacek R., Artursson, Per, He, Liqun, Hellström, Mats, Sjöblom, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755028/ https://www.ncbi.nlm.nih.gov/pubmed/29301589 http://dx.doi.org/10.1186/s13073-017-0511-4 |
Ejemplares similares
-
Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis
por: Kundu, Snehangshu, et al.
Publicado: (2021) -
Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth
por: Pandzic, Tatjana, et al.
Publicado: (2017) -
Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression
por: Larsson, Chatarina, et al.
Publicado: (2020) -
Essential roles for the nuclear receptor coactivator Ncoa3 in pluripotency
por: Percharde, Michelle, et al.
Publicado: (2013) -
Association of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population
por: Yu, Mingxi, et al.
Publicado: (2015)